Key Event Impact on Investors Following the DOJ announcement on May 1, 2025, SelectQuote's stock price fell 19.2%, dropping $0.61 to close at $2.56 per share. Lead Plaintiff Deadline is October 10, 2025 NEW YORK, Aug. 21, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acqui ...

Core Viewpoint - Investors in SelectQuote, Inc. have the opportunity to lead a securities fraud class action lawsuit due to alleged misconduct by the company [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from September 9, 2020, to May 1, 2025, SelectQuote failed to disclose critical information to investors, including: - The company directed Medicare beneficiaries to insurers that compensated SelectQuote the most, regardless of plan quality [2]. - SelectQuote did not provide unbiased comparisons for Medicare Advantage insurance plans [2]. - The company received illegal kickbacks to steer beneficiaries to certain insurers while limiting enrollment in competitors' plans [2]. - SelectQuote's actions resulted in non-compliance with laws, regulations, and contractual obligations [2]. - The company was at risk of regulatory and legal sanctions, including potential violations of the False Claims Act [2]. - Positive statements made by the defendants regarding the company's business and prospects were materially misleading [2]. Participation Information - Investors who suffered losses in SelectQuote are encouraged to participate in the ongoing lawsuit before the lead plaintiff deadline of October 10, 2025 [2]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information [3][4].

Core Viewpoint - A securities class action lawsuit has been filed against SelectQuote, Inc. for allegedly misleading investors regarding its business practices and compliance with regulations [1][2]. Allegations - SelectQuote allegedly steered Medicare beneficiaries to insurance plans that provided the highest commissions rather than those best suited for customers [7]. - The company is accused of failing to provide unbiased Medicare Advantage comparisons as claimed [7]. - SelectQuote reportedly accepted illegal kickbacks to favor certain insurers, limiting competition [7]. - The company is alleged to have been non-compliant with laws, regulations, and contracts, exposing it to regulatory and legal risks, including under the False Claims Act [7]. - Positive statements made by SelectQuote about its business and prospects were misleading and lacked a reasonable basis [7]. Impact on Investors - Following the announcement by the U.S. Department of Justice on May 1, 2025, SelectQuote's stock price fell by 19.2%, decreasing by $0.61 to close at $2.56 per share [3]. Legal Context - Investors have until October 10, 2025, to seek appointment as lead plaintiff in the case [4]. - The law firm representing the investors, Wolf Haldenstein Adler Freeman & Herz LLP, has over 125 years of experience in securities litigation [4]. Key Events - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging that from 2016 to 2021, the company received tens of millions of dollars in illegal kickbacks from insurers [7]. - The DOJ also alleged that SelectQuote conspired with major insurers to discriminate against less profitable beneficiaries, including those with disabilities [7]. - The DOJ concluded that SelectQuote falsely claimed to provide "unbiased coverage comparisons" while steering customers toward higher-paying plans [7].

Core Viewpoint - A securities class action lawsuit has been filed against SelectQuote following the U.S. Department of Justice's intervention in a separate lawsuit, leading to a significant 19% drop in the company's stock price on May 1, 2025 [1][4]. Group 1: Lawsuit Details - The class action, Pahlkotter v. SelectQuote, Inc. et al., seeks to represent investors who acquired SelectQuote securities between September 9, 2020, and May 1, 2025 [2]. - The lead plaintiff deadline for the lawsuit is set for October 10, 2025 [2]. Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements regarding its business practices, particularly in its Medicare Advantage sales [3]. - The DOJ claims that from 2016 to at least 2021, SelectQuote received "tens of millions of dollars" in illegal kickbacks for directing Medicare beneficiaries to specific plans, contradicting its claims of providing unbiased advice [3][8]. - The company allegedly discriminated against less profitable beneficiaries and directed customers to the highest-paying plans, which raises concerns about compliance with applicable laws [3][8]. Group 3: Impact on Stock and Investor Sentiment - Following the announcement of the DOJ's involvement and the class action lawsuit, SelectQuote's stock price has continued to decline, indicating a significant impact on the company's market value [4]. - Hagens Berman is investigating the extent to which SelectQuote's alleged practices may have inflated its financial results, leading to investor losses [7][9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of misleading practices related to Medicare insurance plans, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by October 10, 2025 [4]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote and its executives violated federal securities laws by making false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote the most, regardless of quality [6]. - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage plans and received illegal kickbacks to steer beneficiaries towards certain insurers [6]. - The U.S. Department of Justice filed a complaint stating that from 2016 to at least 2021, SelectQuote received tens of millions of dollars in illegal kickbacks, leading to materially false claims about offering unbiased coverage comparisons [7]. Group 2: Financial Impact - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, amid unusually heavy trading volume [7]. Group 3: Legal Proceedings - Investors who suffered losses exceeding $75,000 in SelectQuote between September 9, 2020, and May 1, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the ability to share in any recovery not affected by the decision to serve as lead plaintiff [8].

Core Viewpoint - The article discusses a class action lawsuit against SelectQuote, Inc. due to allegations of receiving illegal kickbacks from health insurance companies and misleading investors about its business practices [1][2][3]. Group 1: Allegations and Legal Actions - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurers [2]. - SelectQuote is accused of making materially false claims regarding its services, claiming to offer unbiased coverage comparisons while directing beneficiaries to plans that paid the most [2][3]. - The class action lawsuit alleges that SelectQuote failed to disclose critical information about its operations, including the receipt of illegal kickbacks and non-compliance with applicable laws [3]. Group 2: Financial Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [2]. Group 3: Class Action Participation - Investors who purchased SelectQuote securities during the specified Class Period (September 9, 2020, to May 1, 2025) have until October 10, 2025, to file a lead plaintiff motion in the class action lawsuit [1][4].

Should You Join This Class Action Lawsuit? NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT) between September 9, 2020 and May 1, 2025, inclusive. If you purchased or acquired SelectQuote securities, and/or would like to discuss your legal rights and options please visit Selec ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of violations of federal securities laws, particularly concerning misleading statements and illegal kickbacks related to Medicare beneficiaries [4][6][7]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of the quality of the plans [6]. - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage insurance plans and received illegal kickbacks from insurers [6]. - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021, leading to a significant drop in stock price [7]. Group 2: Legal Proceedings and Investor Actions - Investors who suffered losses exceeding $75,000 between September 9, 2020, and May 1, 2025, are encouraged to discuss their legal rights with Faruqi & Faruqi [1][4]. - There is a deadline of October 10, 2025, for investors to seek the role of lead plaintiff in the federal securities class action against SelectQuote [4]. - The lead plaintiff is defined as the investor with the largest financial interest who can adequately represent the class [8].

Core Viewpoint - A securities class action lawsuit has been filed against SelectQuote, Inc. for failing to disclose material information, with a deadline for lead plaintiff applications set for October 10, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit involves SelectQuote and certain executives, alleging violations of federal securities laws during the class period from September 9, 2020, to May 1, 2025 [1][3]. - The U.S. Department of Justice filed a complaint against SelectQuote on May 1, 2025, claiming the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021 [4]. - The DOJ alleges that SelectQuote engaged in a conspiracy to discriminate against less profitable Medicare beneficiaries and made materially false claims about offering unbiased coverage comparisons [4]. Group 2: Financial Impact - Following the DOJ's allegations, SelectQuote's share price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, amid unusually heavy trading volume [4]. Group 3: Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing investors in this case, with a strong track record in recovering investment losses due to corporate fraud [5].

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for misleading statements and illegal practices related to Medicare insurance plans during the Class Period from September 9, 2020, to May 1, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company rather than providing unbiased comparisons [5]. - It claims that SelectQuote received illegal kickbacks to steer beneficiaries towards certain insurers, violating applicable laws and regulations [5]. - The lawsuit asserts that the positive statements made by SelectQuote regarding its business were materially misleading and lacked a reasonable basis [5]. Group 2: Class Action Participation - Investors who purchased SelectQuote securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by October 10, 2025, to represent the class in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4].